THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 72213
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3799
 
  
 
C07K PEPTIDES 2797
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 18957
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 14825
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 13515
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 115134
 
  
 
C07D HETEROCYCLIC COMPOUNDS 9177
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 7234
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 7135

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,233 COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND OTHER LUNG DISEASESNov 21, 17Mar 15, 18[A61K]
2018/0057,603 Combination of IFN-gamma with Anti-ERBB Antibody for the Treatment of CancersFeb 09, 16Mar 01, 18[A61K, C07K]
2018/0057,609 Enhancing Activity of CAR T Cells by Co-Introducing a Bispecific AntibodyAug 30, 17Mar 01, 18[A61K, C07K]
2018/0057,841 METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOROct 27, 17Mar 01, 18[A61K, C12N, C07K]
2018/0051,243 SYSTEM, METHOD, AND DEVICE FOR HIGH-THROUGHPUT, AUTOMATED CULTURING OF GENETICALLY MODIFIED ORGANISMSMar 11, 16Feb 22, 18[C12M]
2018/0044,623 ARTIFICIAL PLACENTA AND METHODS OF PREPARATIONMar 23, 16Feb 15, 18[C12M, G01N]
2017/0360,913 COMPOSITIONS AND METHODS FOR T CELL DELIVERY OF THERAPEUTIC MOLECULESOct 30, 15Dec 21, 17[A61K, C12N, C07K]
2017/0362,669 COMPOSITIONS, KITS, AND METHODS TO DETECT HIV VIRUSDec 11, 15Dec 21, 17[C12Q]
2017/0354,324 VISION TEST FOR DETERMINING RETINAL DISEASE PROGRESSIONNov 04, 15Dec 14, 17[A61B]
2017/0355,778 COMPOSITIONS AND METHODS OF TREATING TUMORSFeb 01, 17Dec 14, 17[A61K, A61N, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9919038 Compositions comprising angiogenic factors and methods of use thereofJan 15, 16Mar 20, 18[A61K, C12N, C07K]
9919054 Protease triggered release of molecules from hydrogelsMay 22, 17Mar 20, 18[A61K, C07K]
9920295 Bioreactor for isolation of rare cells and methods of useFeb 21, 13Mar 20, 18[A61K, C12Q, C12N, C12M, G01N]
9913879 Methods for modulating an inflammatory responseApr 18, 14Mar 13, 18[A61K, C07K]
9913885 Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the sameJul 11, 16Mar 13, 18[A61K, C12N, C07K]
9914535 Passive rotor control mechanism for micro air vehiclesMar 14, 14Mar 13, 18[H02P, G01C, B64C]
9905760 Non-volatile resistance-switching thin film devicesJun 14, 16Feb 27, 18[H01L, G11C]
9895351 Indomethacin analogs for the treatment of castrate-resistant prostate cancerApr 19, 16Feb 20, 18[A61K, C07D]
9895399 Repair of peripheral nerve injuryJan 31, 14Feb 20, 18[A61K]
9895447 Drug-containing PLA implants and methods of use thereofJun 19, 17Feb 20, 18[A61K, A61L]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0305,971 POTENT COMPSTATIN ANALOGSAbandonedApr 18, 17Oct 26, 17[A61K, C07K]
2017/0190,741 COMPSTATIN ANALOGS WITH IMPROVED ACTIVITYAbandonedOct 22, 14Jul 06, 17[C07K]
2017/0119,769 SCAFFOLDS FOR INHIBITORS OF MENIN-MLL INTERACTIONSAbandonedJun 10, 15May 04, 17[A61K, G01N]
2017/0056,524 COMPOSITIONS AND METHODS FOR TARGETED EPIGENETIC MODIFICATIONAbandonedSep 09, 16Mar 02, 17[A61K]
2017/0014,501 METHODS FOR PREVENTING AND TREATING STAPHYLOCOCCUS AUREUS COLONIZATION, INFECTION, AND DISEASEAbandonedFeb 16, 16Jan 19, 17[A61K]
2016/0362,478 CD4-MIMETIC SMALL MOLECULES SENSITIZE HUMAN IMMUNODEFICIENCY VIRUS TO VACCINE-ELICITED ANTIBODIESAbandonedFeb 10, 15Dec 15, 16[A61K, C07K]
2016/0287,726 CATIONIC CONTRAST AGENTS AND METHODS OF USING THE SAMEAbandonedMar 21, 16Oct 06, 16[A61K]
2016/0289,334 Compositions and Methods of Treating TumorsAbandonedJun 03, 15Oct 06, 16[A61K, A61N, C07K]
2016/0167,331 IMPROVED REVERSIBLE ADHESIVES AND METHODS OF FORMING THE SAMEAbandonedAug 01, 14Jun 16, 16[B29C, B32B]
2016/0168,099 NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USEAbandonedAug 13, 15Jun 16, 16[A61K, C07D]
2016/0151,403 SMALL MOLECULE MODULATORS OF P53 FAMILY SIGNALINGAbandonedDec 02, 14Jun 02, 16[A61K]
2016/0151,461 Cardio-Metabolic and Vascular Effects of GLP-1 MetabolitesAbandonedMar 14, 14Jun 02, 16[A61K]
2016/0155,941 CHARGE ORDERED VERTICAL TRANSISTORSAbandonedJul 31, 15Jun 02, 16[H01L]
2016/0096,866 POTENT COMPSTATIN ANALOGSAbandonedSep 10, 15Apr 07, 16[C07K]
2016/0099,409 ULTRATHIN FILM RESISTIVE MEMORY DEVICESAbandonedOct 07, 14Apr 07, 16[H01L, G11C]
2016/0084,820 METHODS OF TREATING OR PREVENTING PERIODONTITIS AND DISEASES ASSOCIATED WITH PERIODONTITISAbandonedSep 16, 14Mar 24, 16[G01N]
2016/0032,316 Purification and Purity Assessment of RNA Molecules Synthesized with Modified NucleosidesAbandonedMar 13, 14Feb 04, 16[C07H, C12P, C12N, C07K]
2016/0017,286 IKAROS INHIBITION TO AUGMENT ADOPTIVE T CELL TRANSFERAbandonedMar 06, 14Jan 21, 16[A61K, C12N]
2016/0001,290 APPARATUS AND METHODS FOR MAKING VESICLESAbandonedJul 02, 15Jan 07, 16[B01L, B01J]
2016/0002,655 PHARMACEUTICAL PROTEINS, HUMAN THERAPEUTICS, HUMAN SERUM ALBUMIN INSULIN, NATIVE CHOLERA TOXIN B SUBUNIT ON TRANSGENIC PLASTIDSAbandonedJul 27, 15Jan 07, 16[C12N, A01H, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.